PL3965790T3 - Triterpeny pentacykliczne w leczeniu bielactwa nabytego - Google Patents
Triterpeny pentacykliczne w leczeniu bielactwa nabytegoInfo
- Publication number
- PL3965790T3 PL3965790T3 PL20726028.2T PL20726028T PL3965790T3 PL 3965790 T3 PL3965790 T3 PL 3965790T3 PL 20726028 T PL20726028 T PL 20726028T PL 3965790 T3 PL3965790 T3 PL 3965790T3
- Authority
- PL
- Poland
- Prior art keywords
- vitiligo
- treatment
- pentacyclic triterpenes
- pentacyclic
- triterpenes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1904890A FR3095754B1 (fr) | 2019-05-10 | 2019-05-10 | Triterpènes pentacycliques dans le traitement du vitiligo |
| PCT/EP2020/063036 WO2020229403A1 (fr) | 2019-05-10 | 2020-05-11 | Triterpènes pentacycliques dans le traitement du vitiligo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3965790T3 true PL3965790T3 (pl) | 2024-08-19 |
Family
ID=67742753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20726028.2T PL3965790T3 (pl) | 2019-05-10 | 2020-05-11 | Triterpeny pentacykliczne w leczeniu bielactwa nabytego |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP3965790B1 (pl) |
| KR (1) | KR20220007600A (pl) |
| CN (1) | CN113905752A (pl) |
| BR (1) | BR112021021131A2 (pl) |
| CA (1) | CA3137549A1 (pl) |
| ES (1) | ES2985540T3 (pl) |
| FR (1) | FR3095754B1 (pl) |
| MX (1) | MX2021013337A (pl) |
| PL (1) | PL3965790T3 (pl) |
| WO (1) | WO2020229403A1 (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10146500A1 (de) * | 2001-09-21 | 2003-04-17 | Beiersdorf Ag | Kosmetische und/oder dermatologische Wirkstoffkombination |
| FR3051116B1 (fr) * | 2016-05-12 | 2019-06-07 | Pierre Fabre Dermo-Cosmetique | Procede de production du celastrol et de derives triterpeniques pentacycliques |
| CN106902125A (zh) * | 2017-02-23 | 2017-06-30 | 中国人民解放军第四军医大学 | 可抑制cd8+t细胞对黑素细胞杀伤的抑制剂、抑制剂组合物及应用 |
-
2019
- 2019-05-10 FR FR1904890A patent/FR3095754B1/fr not_active Expired - Fee Related
-
2020
- 2020-05-11 WO PCT/EP2020/063036 patent/WO2020229403A1/fr not_active Ceased
- 2020-05-11 PL PL20726028.2T patent/PL3965790T3/pl unknown
- 2020-05-11 MX MX2021013337A patent/MX2021013337A/es unknown
- 2020-05-11 KR KR1020217035722A patent/KR20220007600A/ko active Pending
- 2020-05-11 CA CA3137549A patent/CA3137549A1/fr active Pending
- 2020-05-11 ES ES20726028T patent/ES2985540T3/es active Active
- 2020-05-11 EP EP20726028.2A patent/EP3965790B1/fr active Active
- 2020-05-11 CN CN202080034421.XA patent/CN113905752A/zh active Pending
- 2020-05-11 BR BR112021021131A patent/BR112021021131A2/pt active Search and Examination
Also Published As
| Publication number | Publication date |
|---|---|
| FR3095754B1 (fr) | 2021-11-19 |
| EP3965790B1 (fr) | 2024-05-01 |
| KR20220007600A (ko) | 2022-01-18 |
| CN113905752A (zh) | 2022-01-07 |
| BR112021021131A2 (pt) | 2021-12-14 |
| EP3965790C0 (fr) | 2024-05-01 |
| FR3095754A1 (fr) | 2020-11-13 |
| CA3137549A1 (fr) | 2020-11-19 |
| EP3965790A1 (fr) | 2022-03-16 |
| WO2020229403A1 (fr) | 2020-11-19 |
| MX2021013337A (es) | 2021-11-17 |
| ES2985540T3 (es) | 2024-11-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI3849534T1 (sl) | Kombinacija dasatiniba in adagrasiba za uporabo pri zdravljenju nedrobnoceličnega pljučnega raka | |
| EP4066837A4 (en) | USE OF BI853520 IN THE TREATMENT OF CANCER | |
| IL276406A (en) | Osimertinib for use in the treatment of non-small cell lung cancer | |
| IL266198A (en) | Liposomal formulation for use in cancer treatment | |
| CA3292080A1 (en) | Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer | |
| EP3266865A4 (en) | Cell therapeutic agent for cancer treatment and combination therapy with same | |
| EP3761979A4 (en) | USE OF GABOXADOL TO TREAT SUBSTANCE ABUSE | |
| ZA202006886B (en) | R-fadrozole for use in the treatment of aldostonerism | |
| IL269121A (en) | Usl-311 for use in the treatment of cancer | |
| PL3710011T3 (pl) | Triterpeny pentacykliczne do leczenia patologii jamy ustnej - dentystycznych | |
| PL3965790T3 (pl) | Triterpeny pentacykliczne w leczeniu bielactwa nabytego | |
| EP3615064A4 (en) | ENRICHED CELL COMPOSITIONS AND THERAPEUTIC USES | |
| EP3737373A4 (en) | METHODS AND POLYTHERAPY FOR TREATING CANCER | |
| IL276421A (en) | Testosterone therapy methods | |
| IL280262A (en) | Compositions and methods for treating cancer | |
| GB2581035B (en) | Novel compounds and their use in therapy | |
| HK40130794A (zh) | 用於治疗癌症的vs-6063与ch5126766的组合 | |
| HK40078764A (en) | Vs-6063 in combination with ch5126766 for the treatment of cancer | |
| HK40074743A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| HK40064163A (en) | Oligo-benzamide analogs and their use in cancer treatment | |
| HK40061060A (en) | 5-halouracil-modified micrornas and their use in the treatment of cancer | |
| HK40044464A (en) | R-fadrozole for use in the treatment of aldostonerism | |
| HK40031514A (en) | Formulations of milciclib and therapeutic combinations of the same for use in the treatment of cancer | |
| HK40063146A (en) | Novel compounds and their use in therapy | |
| GB201914640D0 (en) | Novel compounds and their use in therapy |